Back to User profile » Dr Kim Abbegail Aldecoa
Paper published by Dr Kim Abbegail Aldecoa:
Commentary
Sunvozertinib in EGFR Exon 20 Insertion NSCLC: Approved but Not Available – Practical Dose Selection Considerations and Real-World Access Challenges
Aldecoa KAT, Arter ZL, Ou SHI, Nagasaka M
Lung Cancer: Targets and Therapy 2026, 17:592922
Published Date: 28 May 2026